DermBiont
Nick leads finance and business development activities at DermBiont.
His passion for the microbiome originates from personal experiences with clostridium difficile (c-diff) and fungal skin infections.
As a Managing Partner at Olive Tree Capital, Nick’s investment expertise spans across asset classes, having led dozens of investments in technology and biotechnology companies, including several private and public microbiome therapeutics companies. He led his previous startup technology company through acquisition and has successfully seeded and structured multiple companies across various industries.
Nick graduated from Boston University’s Questrom School of Business and started his career in commodity markets at CPM Group in New York.
DermBiont
DermBiont’s mission is to become the world’s leading precision dermatology company developing targeted topical therapeutics that treat, cure, and prevent diseases.